// App-Quantinova.ai

: Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT): Guidance to Reduce the Risk of Intracranial Bleeding

Researchers

Presenter

  • Lani Lieberman

Principal Investigators

  • Michael F. Murphy

  • Tamam Bakchoul

  • Stacy Corke

  • Susano Tanael

  • Mette Kjaer

  • Jens Kjeldsen-Kragh

  • Gerald Bertrand

  • Dick Oepkes

  • Jillian M Baker

  • Heather Hume

  • Edwin Massey

  • James B. Bussel

  • Ccile Kaplan

  • Donald M. Arnold

  • Shoma Baidya

  • Greg Ryan

  • Helen Savoia

  • Denise Landry

  • Nadine Shehata

Medical Centers

  • University Health Network, University Hospital, Greifswald, Germany

  • National Health Service (NHS) Blood and Transplant and the Oxford National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Center for Clinical Transfusion Medicine, Eberhard Karls University, Tuebingen, Germany

  • NaitBabies.org, Egham, United Kingdom

  • Canadian Blood Services, Toronto, ON, Canada

  • University of Tromso and University Hospital of North Norway, Hammerfest, Norway

  • University and Regional Laboratories, Skane, Sweden

  • Blood Services of Brittany - EFS L'Etablissement francais du sang, Rennes, France

  • Leiden University Medical Centre, Leiden, Netherlands

  • Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada

  • Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada

  • Department of Kinesiology, University of Montreal, Montreal, Canada

  • Department of Pharmacy, CHU Ste-Justine, Montreal, Canada

  • NHS Blood and Transplant, Oxford, United Kingdom

  • Department of Hematology/Oncology, Weill Cornell Medicine, New York, NY

  • Retired and formerly Institut National de la Transfusion Sanguine, Paris, France

  • Canadian Blood Services, Hamilton, Canada

  • TMS, Australian Red Cross Blood Services, Brisbane, Australia

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Royal Children's Hospital, Melbourne, Victoria, Australia

  • Canadian Blood Services, Ottawa, Canada

  • Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  • Medicine and Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Canada

  • on behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG), Toronto, Canada

  • Department of Medicine, Toronto, Canada

Locations

  • Canada

  • Germany

  • United Kingdom

  • Norway

  • Sweden

  • France

  • Netherlands

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

  • IVIG

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved